Overview

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the safety, tolerability and pharmacodynamics of JNJ-54175446 after multiple consecutive dose administrations

Phase:

Phase 1

Details

Lead Sponsor:

Janssen-Cilag International NV

Treatments:

Amphetamine
Dextroamphetamine
Minocycline